key: cord-0018333-dex1633l
authors: Li, Xian; Wang, Xianjue; Liu, Gang; Xu, Yanan; Wu, Xinlin; Yi, Ru; Jin, Feng; Sa, Chula; Su, Xiulan
title: Antioxidant stress and anticancer activity of peptide-chelated selenium in vitro
date: 2021-06-18
journal: Int J Mol Med
DOI: 10.3892/ijmm.2021.4986
sha: 0ab450f78cd5c7905ccb7e6c3061cce3385bf1ba
doc_id: 18333
cord_uid: dex1633l

The association between selenium and peptide in gastric cancer is an important research topic. The present study reported the facile synthesis of anticancer bioactive peptide (ACBP)-functionalized selenium (ACBP-S-Se) particles with enhanced anticancer activities and a detailed mechanistic evaluation of their ability to regulate oxidative stress in vitro. Structural and chemical characterizations were revealed by ultraviolet absorption, Fourier transform infrared, X-ray photoelectron, nuclear magnetic resonance carbon and hydrogen, energy dispersive X-ray spectroscopy and inductively coupled plasma mass spectrometry, as well as scanning electron microscopy. Sulfhydrylation modifications of ACBP were achieved with Sacetylmercaptosuccinic anhydride via chemical absorption. After the polypeptide was modified by sulfhydrylation, the ACBP chain was linked to sulfhydryl groups by amide bonds to form the ACBP-chelated selenium complex. Two gastric cancer cell lines (MKN-45 and MKN-74 cells) demonstrated high susceptibility to ACBP-S-Se particles and displayed significantly decreased proliferation ability following treatment. The results suggested that the bioactive peptide-chelated selenium particles effectively inhibited the proliferation of MKN-45 and MKN-74 cells in vitro. The genes encoding CDK inhibitor 1A (CDKN1A), cyclin B1, thioredoxin (TXN) and mitogen-activated protein kinase kinase kinase 5 are associated with regulation of oxidative stress, while CDKN1A and TXN protect cells by decreasing oxidative stress and promoting cell growth arrest. Therefore, ACBP-S-Se may be an ideal chemotherapeutic candidate for human cancer, especially gastric cancer.

Oxidative stress refers to aberrant production of active substances, including reactive oxygen species (ROS) and nitrogen free radicals, under various stress stimuli, which leads to an unbalanced physiological status or oxidative stress (OS)-associated damage via oxidation-reduction reactions (1) . Previous studies revealed that ROS generated by cells under OS are involved in gastric tumorigenesis (2, 3) .

ROS have been shown to promote gastric carcinogenesis in both clinical studies and mouse models in vivo (4, 5) . The dysregulation of ROS promotes tumorigenesis and the development of abnormalities due to its ability to increase aberrant cell proliferation, survival and migration in vivo (4, 5) . Moreover, aberrant production of ROS also induces dNA damage, leading to genomic instability, tumorigenicity and subsequent tumor progression (6) . For example, ROS are constantly generated in cells as a consequence of endogenous metabolism, infection/inflammation and/or exposure to environmental toxins (6) . If the accumulation of ROS overwhelms the death threshold, cellular apoptosis levels increase, which enhances the antitumor effects of ROS production (7). Fuloria et al (8) confirmed that ROS alleviate certain types of cancer, such as oral (9) and gastric cancer (Gc) (10) , and that the redox state in cells is an important factor for subsequent tumor formation potential; thus, cellular redox states are potential therapeutic targets for cancer treatment. Finally, ROS may contribute to the regulation of apoptosis (9). Selenium (Se), with a narrow range between deficiency and toxic effects (11) , is a component of the antioxidant system, and one of the most important trace elements in organisms; Se supplements may be effective anti-cancer agents (12, 13) . Moreover, Se is a key component of the antioxidant system (14) and substantially contributes to human health. The chemical forms of Se regulate its toxicity, bioavailability and diverse biological effects, including anti-inflammatory, antioxidant and immune effects, and lead to severe tissue damage and health complications (15) , and supplementation with Se improves the redox system, promotes proper immune system function and has anticarcinogenic effects (16) . Se deficiency leads to heart disease, hypothyroidism and a weakened immune system, but excess exposure to Se results in gastrointestinal disturbance

and hair and nail changes (17, 18) . Se enhances the function of the immune system, improves proliferation and biofunction of immune system cells and enhances phagocytosis of immune system cells, thereby improving the immune function and ability to resist disease (19, 20) . In addition, at higher concentrations, Se exhibits pro-oxidant properties that may be a potential mechanism for cancer therapy (21) . Furthermore, Se inhibits hepatocyte necrosis and dNA damage by inhibiting cyclophosphamide-induced OS (22) . Previous studies have confirmed that Se may be a promising therapeutic for cancer (23, 24) , as it promotes the formation of tumor microenvironment that inhibits cancer proliferation. Following cancer surgery, Se supplementation decreases the risk of cancer recurrence, decreases the toxicity and side effects of chemotherapy and radiotherapy and improves the curative effect of anticancer drugs (25, 26) . Furthermore, Se, as an essential component of selenocysteine-containing proteins, is involved in cellular biochemistry and function (27) .

Selenoproteins are essential for human heath, and have been characterized as antioxidant enzymes, protecting against damage caused by free radicals (28) . Further studies on selenoprotein gene expression and cytokine content in the chicken thymus have shown that decreased selenoprotein expression levels induce OS (29, 30) . In addition, Se-containing molecules exhibit antioxidant properties associated with tumor growth, metastasis, angiogenesis and drug resistance (31) . For example, Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs (32) . An exciting area of drug design research is the synthesis of the polypeptide chelated selenium, which exhibits cancer stem cell line inhibition and antioxidant activity (33) . The anticancer bioactive peptide (AcBP) is a low-molecular weight active peptide extracted from goat liver (34) . We previously found that AcBP exhibits antineoplastic activity and inhibits tumor growth in nude mice with dutch gallbladder carcinoma (35) . It also increases the chemotherapeutic sensitizing effect and decreases side effects associated with chemotherapy (35) . A number of non-natural selenium-containing amino acid derivatives and peptides have been prepared by chemical synthesis to establish an anti-Gc system for treating disease (36) . Selenocarbohydrates, selenoamino acids and selenopeptides are utilized in the synthesis of biological compounds. To the best of our knowledge, however, associated OS genes and potential antitumor efficacy of synthesized AcBP-chelated selenium [AcBP functionalized selenium (AcBP-S-Se)] particles have not been previously demonstrated. Furthermore, elucidating the molecular mechanism underlying the antioxidant regulatory effects of the peptide-chelated selenium is important for revealing its ability to regulate tumorigenesis and drug resistance. In addition, selenium nanoparticles loaded with anticancer molecules offer a novel strategy for cancer treatment (37) . Moreover, lncRNAs regulate OS to maintain homeostasis (38) .

Here, sulfhydrylation modifications of AcBP was performed with S-acetylmercaptosuccinic anhydride (S-AMSA) via chemical absorption. Following sulfhydrylation, the binding site of Se was used to link the sulfhydryl group. The molecular mechanism underlying the antioxidant regulation and antitumor effects of AcBP-S-Se on tumor cell lines was investigated in vitro.

Materials. AcBP (8, Synthesis of ACBP-S-Se particles. Briefly, 2.08 g 3-morpholine-propanosulfonic acid (MOPS; cat. no. 1001878657, Sigma-Aldrich; Merck KGaA) was dissolved in ddH 2 O (200 ml) to prepare MOPS-buffered solution. AcBP (1 g) was dissolved in MOPS solution with a pH of 7.4 to obtain AcBP solution. Then, 0.4 g S-AMSA was added to the AcBP solution and incubated at 25˚C for 2 h, during which pH was maintained at 7.4. The sample was stored in nitrogen to avoid air oxidation products. Then, 0.05 mol/l hydroxylamine hydrochloride was added and the reaction proceeded at 25˚C for 3 h. Next, 0.66 g sodium selenite was added to the AcBP-S solution at 30˚C for 6 h to obtain the raw ACBP-S-Se product, and gel chromatography column purification was performed again to produce a pure AcBP-S-Se solution [G250 column; with PBS (pH, 7.4; 1 mol/l) as the mobile phase].

The pure AcBP-S-Se was dried by vacuum refrigeration dryer at 35˚C for 48 h, then the ACBP-S-Se particles underwent chemical structure characterization.

FT-IR spectra were recorded using a Nicolet FT-IR 5700 spectrophotometer (Thermo Fisher Scientific, Inc.) at 25˚C. characterization of the components (AcBP and AcBP-S-Se) was performed and the samples were triturated with KBr at a ratio of 1:100 and pressed into pellets for FT-IR spectroscopic analysis at 500-4,000 cm -1 .

X-ray photoelectron spectroscopy (XPS). XPS (Thermo Fisher, EScALAB 250Xi; Thermo Fisher Scientific, Inc.) was used to determine the elemental compositions of AcBP and AcBP-S-Se, for which full (pass energy, 100 eV) and high-resolution spectra (pass energy, 20 eV) were recorded.

Particle morphology. The morphology of AcBP-S-Se particles was examined by scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EdX). AcBP-S-Se was carefully dried to maintain the surface structure and then mounted, sputter-coated with gold and observed under a Hitachi S-570 SEM microscope (Hitachi, Ltd.) at x200 magnification.

Carbon (13C) and hydrogen (H) nuclear magnetic resonance (NMR) spectra. H and 13c NMR spectra were recorded in deuteroxide (d 2 O) at 17˚C using a Bruker DRX 500 spectrometer (Bruker corporation). For each spectrum, ~1,500 transients were collected using the following acquisition parameters: 3 sec delay between pulses, 90˚ pulse for 5.4 µsec and 1 m sec contact time. data were acquired and processed using Topspin 2.1 (Bruker corporation).

The Se content in AcBP-S-Se particles was determined by IcP-MS (cat. no. 7900IcP, Agilent Technologies, Inc.) as previously described (39) . Following ignition, the tested elements and internal standard (10 bbp TuneA) were set according to the standard model. The parameters were as follows: collision gas, H 2 /He; flow velocity, 5.5 ml/min, co sensitivity, 20,000 counts per second/parts per billion (ppb). U signal maximum was adjusted and Se in AcBP-S-Se was measured. The amount of selenium bound to AcBP was determined as follows: n Se /n AcBP =(m Se /M Se )/(m AcBP /M AcBP )=(c Se /M Se )/(c AcBP /M AcBP )= 1,228c Se /c AcBP , where, n=moles, m=mass, M=molar mass, c Se =concentration of Se determined by IcP-MS and c AcBP =concentration of AcBP determined by Nanodrop 2000C (Thermo Fisher Scientific, Inc.).

Drug treatment. The cell lines were pre-plated in 6-well culture dishes (corning, Inc.) at a density of 5x10 5 cells/well at 37˚C in a humidified chamber containing 5% CO 2 . cells were cultured in RPMI-1640 (cat. no. 61870036; Invitrogen; Thermo Fisher Scientific, Inc.) growth medium or DMEM (cat. no. 10566-016, Invitrogen; Thermo Fisher Scientific, Inc.) supplemented with 10% FBS (cat. no. 16000-044; Gibco; Thermo Fisher Scientific, Inc.) and 100 U/ml P/S (cat. no. 15140-122; Gibco; Thermo Fisher Scientific, Inc.) at 37˚C in a humidified chamber containing 5% CO 2 . When the cell confluence reached 70%, drug treatment (0, 5, 10, 20, 40 and 80 mg/ml ACBP-S-Se) was performed at 37˚C for 24 h. Optimization of the AcBP-S-Se concentration was performed as previously described (40) .

Cell proliferation. The proliferation of MKN-45 and MKN-74 cells following AcBP-S-Se treatment was assessed using an Incucyte Live cell Analysis system (ZOOM; Essen BioScience). Briefly, MKN-45 and MKN-74 cells were inoculated into 96-well plates at a density of 5x10 3 /well and cultured at 37˚C for 24 h. Following ACBP-S-Se treatment, the 96-well plates were placed in the Incucyte Live cell workstation and cell proliferation was recorded for 24 h at intervals of 2 h. control groups were not treated with AcBP-S-Se (0 mg/ml); experimental groups were treated with different concentrations of AcBP-S-Se (5, 10, 20, 40 and 80 mg/ml) at 37˚C for 24 h. degree of cell fusion was counted and cell proliferation rate was calculated by Incucyte Live cell Analysis system.

Cell migration. The migration of MKN-45 and MKN-74 cells following AcBP-S-Se treatment was determined using an IncuCyte Live Cell workstation. Briefly, confluent MKN-45 and MKN-74 cells were inoculated into 96-well plates at a density of 5x10 4 /well with serum-free RPMI-1640 growth medium at 37˚C for 24 h. Following scratching, cells were placed in the Incucyte Live cell workstation and migration was recorded for 36 h at intervals of 2 h. control groups were not treated with any additional AcBP-S-Se (0 mg/ml); experimental groups were treated with different concentrations of AcBP-S-Se (1 and 5 mg/ml) at 37˚C. After the assay, the data of the scratch wound healing were calculated using Incucyte Live cell Analysis system. R NA ext raction a nd sequencing. M K N-45 cel ls (5x10 5 cells/well) were treated with AcBP-S-Se (5 mg/ml) at 37˚C for 24 h, then collected to extract RNA. Total RNA was isolated and purified using TRIzol ® (cat. no. 15596018; Invitrogen; Thermo Fisher Scientific, Inc.) reagent according to the manufacturer's instructions. The total RNA quantity and purity were analyzed using Agilent 2100 Bioanalyzer and RNA 1000 Nano Labchip kit (both Agilent Technologies, Inc.) with RNA integrity number >7.0. Then, ~5 ug total RNA was used to deplete ribosomal RNA using a Ribo-Zero™ rRNA Removal kit (Illumina, Inc.) according to the manufacturer's instructions. The RNAs were fragmented using divalent cations 94˚C for 4 min. RNA fragments were reverse-transcribed to create cdNA, which was used to synthesize U-labeled second-stranded dNAs with E. coli dNA polymerase I, RNase H and dUTP. A-base was added to the blunt ends of each strand, preparing them for ligation to the indexed adapters. Each adapter contained a T-base overhang for ligating the adapter to the A-tailed fragmented dNA. Single-or dual-index adapters were ligated to the fragments and size selection was performed with AMPureXP beads. Then, U-labeled second-stranded dNAs were treated with heat-labile UDG enzyme at 37˚C for 10 min. The sequences of the forward and reverse primers are shown in Table I . The ligated products were amplified with PCR using primers as follows: Forward, 5'-AAT GAT AcG GcG Acc Acc GAG ATc TAc Ac-3' and reverse, 5'-cAA GcA GAA GAc GGc ATA cGA GAT-3'. The thermocycling conditions were: Initial denaturation at 95˚C for 3 min; 8 cycles of denaturation at 98˚C for 15 sec, annealing at 60˚C for 15 sec and extension at 72˚C for 30 sec; and final extension at 72˚C for 5 min. The average insert size for the final cDNA library was 300 bp (±50 bp). The final library concentration was determined by PCR and then multiplexed in a single sequencing lane for a final volume of 20 µl at 10 nM before sequencing. Paired-end sequencing was performed on an Illumina HiSeq 4000 according to the manufacturer's instructions.

Transcript assembly. Firstly, cutadapt-1.10 (41) (cutadapt. readthedocs.io/en/stable/) was used to remove reads that contained adapter contamination and low quality or undetermined bases. The sequence quality was verified using FastQC v0. 10 Long non-coding (lnc)RNA identification. Transcripts that overlapped with known mRNAs and transcripts <200 bp in length were discarded. cPc0.9-r2 (46) (cpc2.cbi.pku.edu.cn/) and cNcI2.0 (47) (bioinfo.org/software/cnci) with default parameters (cpc2-i novel.fa-ocpc2.out and cNcI.py-f novel. fa-o cNcI.result-p 1-mve-g novel.gtf-d genome.fa, respectively) were used to predict transcripts with coding potential. All transcripts with cerebral performance category score <-1 and cNcI score <0 were removed and remaining transcripts were considered to be lncRNAs.

StringTie was used to assess expression levels of mRNAs and lncRNAs by calculating FPKM. The differentially expressed mRNAs and lncRNAs were selected with log2 (fold change) ≥1 or log2 (fold change) ≤-1 and P-value <0.05 using R package edgeR (48) (bioconductor. org/packages/release/bioc/html/edgeR.html/).

To investigate the function of lncRNAs, the cis-target genes of lncRNAs were predicted. lncRNAs may serve a cis role acting on neighboring target genes (49, 50) . A total of 100,000 up-and downstream coding genes were selected by Python Script (ccb. jhu.edu/software/stringtie/) (51) . Then, functional analysis of target genes for lncRNAs with Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment was performed, as previously described (52) .

Reverse transcription-quantitative (RT-q)PCR. Following drug treatment (0 and 5 mg/ml AcBP) for 24 h, total RNA was extracted from cells using TRIzol ® reagent (cat. no. 15596018; Invitrogen; Thermo Fisher Scientific, Inc.), and cDNA was synthesized according to the manufacturer's instructions using Prime Script™ RT reagent kit with gdNA Eraser (cat. no. RR047A; Takara Biotechnology co., Ltd.). The concentration of AcBP was determined based on the cell proliferation rate. For PCR amplification, specific primers were designed using the National center for Biotechnology Information website (ncbi.nlm.nih.gov) and commercially synthesized by Invitrogen (Thermo Fisher Scientific, Inc.). RT-qPcR was performed on a Thermo Pikoreal machine (Thermo Fisher Scientific, Inc.) with commercial kit (cat. no. RR820A; TB Green ® Premix Ex Taq™ II; Takara Biotechnology co., Ltd.).

PcR amplification was performed as follows: Initial denaturation cycle for 5 min at 95˚C, followed by 35 cycles of denaturation at 95˚C for 30 sec, annealing at 58˚C for 30 sec and extension at 72˚C for 30 sec. The ubiquitously expressed β-actin gene was used as an internal control. The PcR quantities were confirmed by melting curve analysis and all experiments were performed in triplicate. The relative mRNA expression was calculated using the 2 -ΔΔcq method (53) . The primers for RT-qPcR analysis are shown in Table I .

Statistical analysis. Statistical analysis was performed using Graphpad Prism (version no. 6.02; GraphPad Software, Inc.). Data are presented as the mean ± standard deviation of six independent repeats. data containing two samples were analyzed using paired Student's t-test. comparisons in datasets containing >3 groups were evaluated by one-way ANOVA followed by Bonferroni's post hoc test. P<0.05 was considered to indicate a statistically significant difference.

Determination of the chemical structure of ACBP-S-Se by UV and FT-IR spectroscopy. UV absorption value of AcBP was 203 nm (Fig. 1A) . The UV absorption of selenium chelated by AcBP was notable at 206 and 210 nm. New forms of -NH and -OH were predicted. Weak absorption was observed at 220 nm, and -cNO and -c-S bond formation may have occurred. The absorption intensity of the carbonyl groups were increased because-NH and -OH are hydrophilic groups, and the λ max of UV absorption therefore increased from 0.12 to 0.62 mm (Fig. 1A and c) . compared with the maximum absorption peak of pure AcBP (λ max =206 nm), that of AcBP-S-Se (λ max =210-220 nm) was at a longer wavelength (4-14 nm). The height of the maximum absorption peak was notably increased for AcBP-S-Se. At 210-220 nm, there were two high absorption peaks, which represented the characteristic absorption peaks of -c=O, -NH and -OH in-RcONHR'. Secondary amide functional groups may have also existed in the product following sulfhydrylation and deacetylation of AcBP. From the FT-IR analysis, distinction between the two maps (AcBP and AcBP-S-Se) was notable, indicating that the AcBP-S-Se curve represented the formation of a new substance that differed from AcBP (Fig. 1B) . In the AcBP-S-Se curve, vibrational peaks of the Se-Se bond were observed at 535 and 640 cm -1 , and absorption peaks of the c-Se bond were observed at 736.8, 721.0 and 775.0 cm -1 . Moreover, the unique absorption peak of Se occurred at 2,336 cm -1 , the characteristic absorption peak of-SH occurred at 2,600 cm -1 and those of secondary amides occurred at 3,391.0, 1,585.5 and 1,406.2 cm -1 . These peaks differed from those in the AcBP curve as the absorption strength was enhanced. These results indicated that AcBP bound with Se to form AcBP-S-Se, and the AcBP chain was linked with sulfhydryl groups by amide bonds to form the AcBP-chelated selenium complex.

Determination of ACBP-S-Se chemical structure by 13C and H NMR. In the H NMR spectra, absorption peaks of -OH, -NH and -SH were detected at the attachments of δ2.31, δ6~8.2 and δ1.43, respectively (Fig. 1d) . At the same time, different absorption peaks and chemical shifts were observed. In the AcBP spectra, the absorption peak δ2.31 of -OH was shifted to δ2.1 in the AcBP-S-Se spectra. The δ2.93 of -SH-SH absorption peak was observed in the AcBP-S-Se spectra, while no absorption peak of -SH-SH was observed in the AcBP spectra. In the 13c NMR spectra, absorption peaks of cHO and -c-S at δ100 and absorption peaks of different degrees were simultaneously observed. The absorption peak of -Se-c was detected at δ180 with weak absorption peak in the AcBP-S-Se spectra, but no absorption peak of -Se-c was observed in the AcBP spectra. These results showed that binding occurred between the bioactive polypeptide and Se to different extents, and the molecular structure of AcBP-S-Se was thus inferred.

Determination of ACBP-S-Se chemical structure by XPS.

Both ACBP and ACBP-S-Se exhibited significant differences Fig. 2 ). As determined by the XPS spectra of nitrogen, the binding energy decreased from 399.65 eV for AcBP and to 399.02 eV for AcBP-S-Se. However, as determined by the XPS spectra of sulfur, the binding energy increased from 166.8 eV for AcBP and up to 167.57 eV for AcBP-S-Se. Additionally, the binding energy of Se formed at 56.2 eV in AcBP-S-Se and a new-SH=Se bond in AcBP-S-Se was formed, resulting in increased electronegativity of Se 3d and binding energy.

AcBP exhibited a coarse fibrous morphological structure (Fig. 3A) .

According to the morphological analysis of AcBP-S-Se, the particle structure exhibited an average uneven grain that was 5 µm in diameter (Fig. 3c) . compared with AcBP, AcBP-S-Se exhibited decreased distribution of elements c, N and O but increased distribution of Se and S ( Fig. 3B and d) .

Se content reached up to 0.28% (Fig. 3d) . The Se content was 829.030 He/ppb at an AcBP to Se ratio of 2:1 (Table III) . The mole ratio of Se content in the AcBP molecule was 2.1. 

Proliferation of MKN-45 and MKN-74 cells was inhibited following treatment with AcBP-S-Se and the number of cells were inhibited in a dose-dependent manner (Fig. 4A and B) . The inhibition of MKN-45 and MKN-74 cell proliferation was not notably different as AcBP-S-Se concentration increased from 5 to 80 mg/ml.

The wound healing ability of MKN-45 and MKN-74 cells decreased following treatment with AcBP-S-Se in a dose-dependent manner (Fig. 4c and d) . These results AcBP-S-Se, anticancer bioactive peptide functionalized selenium; RSd, relative standard deviation.

indicated that AcBP-S-Se at concentrations from 1 to 5 mg/ml inhibited cell migration (Fig. 4E and F) . Intrinsic apoptotic signaling pathway in response to oxidative stress GO:0034599 cellular response to oxidative stress GO:0036475

Neuron death in response to oxidative stress GO:0043619

Regulation of transcription from RNA polymerase II promoter in response to oxidative stress GO:0097193

Intrinsic apoptotic signaling pathway GO:1900407 Regulation of cellular response to oxidative stress GO:1900408 Negative regulation of cellular response to oxidative stress GO:1902175 Regulation of oxidative stress-induced intrinsic apoptotic signaling pathway GO:1902176 Negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway GO:1902882 Regulation of response to oxidative stress GO:1902883 Negative regulation of response to oxidative stress GO:1903202 Negative regulation of oxidative stress-induced cell death GO:1903204 Negative regulation of oxidative stress-induced neuron death GO:1903376 Regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway GO:1903377 Negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway hsa04068

FoxO signaling pathway hsa04115 p53 signaling pathway treatment in MKN-45 cells. The screening results and enrichment analysis of OS-associated genes are shown in Table IV . From the functional enrichment analysis of OS-associated genes, a total of 75 genes with significant differences were selected (Fig. 5A) . From the gene interaction mapping, cdK inhibitor 1A (cdKN1A), cyclin B1 (ccNB1), thioredoxin (TXN) and mitogen-activated protein kinase kinase kinase 5 (MAP3K5) were extracted based on the roles of genes with which they were associated and the significantly enriched pathways, which were used for TcGA analysis (Fig. 5B ).

According to the interaction of genes associated with OS and lncRNAs, networks of OS genes and lncRNA interactions Figure 7 . Expression of hcdKN1A, hccNB1, hTXN and hMAP3K5 detected by RT-qPcR. The relative hcdKN1A, hccNB1, hTXN and hMAP3K5 gene expression levels following treatment with 5 mg/ml AcBP-S-Se were detected by RT-qPcR. AcBP-S-Se (0 mg/ml) was used as the control. * P<0.05 vs. control. RT-q, reverse transcription-quantitative; h, human; cdKN1A, cdK inhibitor 1A; ccNB1, cyclin B1; MAP3K5, mitogen-activated protein kinase kinase kinase 5; TXN, thioredoxin; AcBP-S-Se, anticancer bioactive peptide functionalized selenium. (lncRNA FPKM>5) were constructed via lncRNA trans and cis analysis (TRANS_ENERGY<-50; Fig. 6A ). The results showed that the network contained 55 genes associated with OS and 37 lncRNAs.

The selected lncRNAs included MSTRG.13268.2, ENST00000508832, ENST00000580180, ENST00000454068, ENST00000607476, ENST00000504539, ENST00000326677, ENST00000448718, ENST00000531126 and MSTRG.5031.1. Expression levels of the four selected OS-associated genes in The cancer Genome Atlas (TcGA) were assessed. Expression of cdKN1A increased following treatment with AcBP-S-Se but was lower in tumor samples than in paracancerous samples ( Fig. 6B ; Table V ). The expression of the other three genes decreased following treatment with AcBP-S-Se and was lower in tumor samples than in paracancerous samples, however this was not significantly different.

Relative gene expression levels. cdKN1A, ccNB1, TXN and MAP3K5 gene expression levels in GES-1, MKN-45 and MKN-74 cells were analyzed by RT-qPcR (Fig. 7) . In GES-1, MKN-45 and MKN-74 cells, the gene expression levels of CDKN1A and TXN were significantly increased following AcBP-S-Se treatment compared with the control. In addition, the gene expression levels of cdKN1A and TXN in GES-1 cells were significantly different between the control and AcBP-S-Se treatment groups; however, the gene expression levels of MAP3K5 were significantly increased in MKN-45 but decreased in MKN-74 cells following AcBP-S-Se treatment. The results indicated that cdKN1A and TXN protected cells with decrease OS and inhibited cell growth.

Gc is a threat to human health worldwide; each year ~990,000 people are diagnosed with Gc worldwide, of whom ~738,000 die from this disease (54) . A previous study demonstrated that ACBP combined with oxaliplatin significantly inhibits proliferation of MKN-45 cells (35) . Recently, the replacement of peptides with chemical modifications to achieve the same therapeutic effects as their natural peptide counterparts in combined chemotherapeutics has been developed (55) . Furthermore, the incorporation of the Se atom into amino acids and peptides is primarily restricted to selenocysteine derivatives (56) and there is a need to develop synthesis of amino acid-derived chiral Se compounds for evaluation of antioxidant, antihypertensive, anti-inflammatory and immunomodulatory effects (56) . Here, AcBP was modified by sulfhydrylation and combined with Se to form AcBP-chelated Se, and its properties and inhibitory effect on Gc cells in vitro were investigated.

FT-IR, XPS, 13c and H NMR, SEM, EdX and IcP-MS analysis demonstrated that new functional groups were formed, such as -c-Se, Se-Se, -SH=Se and -cONH. IcP-MS is used to determine the single elements and perform multielement analysis of synthetic drugs (39) . The higher content of Se in AcBP-S-Se than in AcBP may indicate that Se was successfully incorporated into the molecular chain of AcBP. Moreover, Se is a trace element that is beneficial to humans depending on its concentration and chemical speciation (57, 58) . The mechanism underlying the synthesis of AcBP, S-SAMS and sodium selenite are shown in Fig. 8 . Studies have shown that different Se compounds decrease cancer growth, thus serving as potential anticancer drugs (59, 60) . Se deficiency has been shown to increase cell apoptosis and decrease viability; Se supplementation may mitigate these alterations (28) . The present study showed that AcBP-S-Se at 5 mg/ml effectively inhibited proliferation of MKN-45 and MKN-74 cells. In addition, the wound healing ability of MKN-45 and MKN-74 cells following AcBP-S-Se treatment decreased.

Selenocysteine has high glutathione peroxidase activity and can clear free radicals in the human body (61) . Although several functions of selenoproteins are unknown, many disorders are associated with alterations in selenoprotein expression levels or activity (62) . Selenium insufficiency and polymorphisms or mutations in genes encoding selenoproteins and synthesis cofactors are involved in the pathophysiology of numerous diseases, including immune disease, Gc and colorectal cancer (31) . From the perspective of using OS to investigate the competing endogenous RNA mechanism of AcBP-S-Se in the treatment of Gc, it is necessary to determine expression changes in OS-associated genes following AcBP-S-Se treatment. Here, analysis of OS-associated pathways and genes resulted in detection of functional genes.

Among these genes, those that were downregulated were determined to encode selenoproteins. Furthermore, Se-specific effects are caused primarily by Se deficiency, rather than high Se levels (63) . A total of 75 genes with significantly different functional enrichment were selected, and cdKN1A, ccNB1, TXN and MAP3K5 were selected from the gene interaction map. cdKN1A (also known as p21), a cell cycle-dependent kinase suppressor molecule, protect cells from OS damage (64) . CCNB1 also inhibits certain factors in the ubiquitin (Ub) proteasome (65) . For example, hydrogen peroxide prevents Ub from binding to late-promoting complex (anaphase-promoting complex/cyclosome) substrates, which prevents the degradation of CCNB1 and thus inhibited cell proliferation caused by OS. Increased CCNB1 expression has been observed in several types of cancer (66); for example, the expression of ccNB1 in Gc tissue is higher than that in normal gastric tissue (67) . However, AcBP-S-Se treatment decreased expression levels of ccNB1 in MKN-45 and MKN-74 cells. TXN serves an important role in cellular antioxidant defense (67, 68) . MAP3K5, also known as apoptotic signal-regulated kinase 1, regulates the biological and physiological processes of apoptosis, immunity and gastric emptying by regulating the flow of apoptotic kinases (69, 70) . Furthermore, MAP3K5, which is activated in response to stress signals, serves an important role in OS regulation, cell proliferation, differentiation and death and immune response (71) . It has been shown that a molecular target of ROS, TXN (also known as Trx), is an inhibitor of MAP3K5 (72). Moreover, oxidation via ROS disrupts the binding of Trx to MAP3K5, resulting in apoptosis (73) . The present results showed that formation of AcBP-S-Se negatively regulated MAP3K5 activity, thus attenuating the proapoptotic signal in MKN-74 cells. Inhibition of apoptosis via this mechanism results in increased proliferation and survival, thereby increasing the likelihood of tumorigenesis and/or metastasis. Therefore, OS is associated with the occurrence and development of cancer. OS results in cell apoptosis/death, stressors alter micro (mi)RNA expression level profiles and miRNAs serve a role in the cell response to stress (38) .

In summary, the application of sulfhydrylation and deacetylation is an effective method to enhance the chelating efficiency of ACBP and Se. According to the UV, FT-IR and 13c NMR, H NMR, XPS, EdX and IcP-MS analysis, Se was chelated to AcBP via sulfhydrylation; the sulfhydryl group was used as the binding site of Se and increased chelation. Finally, the results suggested that AcBP-S-Se effectively inhibited MKN-45 and MKN-74 cell proliferation and migration in vitro and may have clinical applications.

ROS signalling in the biology of cancer

MicroRNAs serve as a bridge between oxidative stress and gastric cancer (Review)

Interplay between mitochondrial peroxiredoxins and ROS in cancer development and progression

Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells

Reactive oxygen species-mediated tumor microenvironment transformation: The mechanism of radioresistant gastric cancer

Occurrence, biological consequences, and human health relevance of oxidative stress-induced dNA damage

Targeting cScs in tumor microenvironment: The potential role of ROS-associated miRNAs in tumor aggressiveness

comprehensive review of methodology to detect reactive oxygen species (ROS) in mammalian species and establish its relationship with antioxidants and cancer. Antioxidants (Basel) 10: 128, 2021. 9. choudhari SK, chaudhary M, Gadbail AR, Sharma A and Tekade S: Oxidative and antioxidative mechanisms in oral cancer and precancer: A review

Reactive oxygen and nitrogen species in carcinogenesis: Implications of oxidative stress on the progression and development of several cancer types

Ultrasonic assisted dispersive liquid-liquid microextraction method based on deep eutectic solvent for speciation, preconcentration and determination of selenium species (IV) and (VI) in water and food samples

Endoplasmic reticulum stress and oxidative stress drive endothelial dysfunction induced by high selenium

Selenium exposure and cancer risk: An updated meta-analysis and meta-regression

Selenium involvement in mitochondrial function in thyroid disorders

Selenium (Se) plays a key role in the biological effects of some viruses: Implications for cOVId-19

Simultaneous speciation analysis of inorganic arsenic, chromium and selenium in environmental waters by 3-(2-aminoethylamino) propyltrimethoxysilane modified multi-wall carbon nanotubes packed microcolumn solid phase extraction and IcP-MS

Selenium exposure and depressive symptoms: The coronary artery risk development in young adults trace element study

Simultaneous multi-channel hydride generation atomic fluorescence spectrometry determination of arsenic, bismuth, tellurium and selenium in tea leaves

Brain, immune system and selenium: A starting point for a new diagnostic marker for Alzheimer's disease?

Selenium, selenoproteins, and immunity

Supplementation with Selenium yeast on the prooxidant-antioxidant activities and anti-tumor effects in breast tumor xenograft-bearing mice

Selenium-alleviated hepatocyte necrosis and dNA damage in cyclophosphamide-treated geese by mitigating oxidative stress

Selenium and human cancer

The epidemiology of selenium and human cancer

Selenoxide elimination manipulate the oxidative stress to improve the antitumor efficacy

Se@SiO 2 -FA-cuS nanocomposites for targeted delivery of dOX and nano selenium in synergistic combination of chemophotothermal therapy

The influence of selenium on immune responses

Selenium-dependent antioxidant enzymes: Actions and properties of selenoproteins

Selenium deficiency downregulates selenoproteins and suppresses immune function in chicken thymus

Selenoproteins and heat shock proteins play important roles in immunosuppression in the bursa of Fabricius of chickens with selenium deficiency

Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: Preclinical and clinical development

Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models

A kind of whey protein peptide with antioxidant activity-selenium chelate and its preparation method and application. Patent cN108893514A

Effect of anticancer bioactive peptide on the gene expression of human gastric cancer BGc-823 cells

New bioactive peptide reduces the toxicity of chemotherapy drugs and increases drug sensitivity

Selenazolidine: A selenium containing proline surrogate in peptide science

Novel functionalized selenium nanoparticles for enhanced anti-hepatocarcinoma activity in vitro

lncRNA-triggered macrophage inflammaging deteriorates age-related diseases

IcP-MS: Analytical method for identification and detection of elemental impurities

Bioactive peptides sensitize cells to anticancer effects of oxaliplatin in human colorectal cancer xenografts in nude mice

cutadapt removes adapter sequences from high-throughput sequencing reads

The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia

HISAT: A fast spliced aligner with low memory requirements

StringTie enables improved reconstruction of a transcriptome from RNA-seq reads

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

cPc: Assess the protein-coding potential of transcripts using sequence features and support vector machine

Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts

edgeR: A bioconductor package for differential expression analysis of digital gene expression data

deregulation of a cis-acting lncRNA in non-small cell lung cancer may control HMGA1 expression

Gene regulation by long non-coding RNAs and its biological functions

Identification and comparative analysis of long non-coding RNA in the skeletal muscle of two dezhou donkey strains

Gene ontology analysis for RNA-seq: Accounting for selection bias

Effect of sodium alginate on mouse ovary vitrification

Estimates of worldwide burden of cancer in 2008: GLOBOcAN

Improvements in chemical carriers of proteins and peptides

Selenium-containing proteins/peptides from plants: A review on the structures and functions

Ionic liquid-assisted separation and determination of selenium species in food and beverage samples by liquid chromatography coupled to hydride generation atomic fluorescence spectrometry

Novel approaches for selenium speciation in foodstuffs and biological specimens: A review

RGd peptide-conjugated selenium nanoparticles: Antiangiogenesis by suppressing VEGF-VEGFR2-ERK/AKT pathway

Emerging anticancer potentials of selenium on osteosarcoma

Selenium-containing polypeptide and its use in medicine, food etc. Patent cN1603338A

Expression of selenoprotein genes and association with selenium status in colorectal adenoma and colorectal cancer

Selenium regulation of the selenoprotein and nonselenoprotein transcriptomes in rodents

Cyclin dependent kinase inhibitor 1 C is a female-specific marker of left ventricular function after acute myocardial infarction

Polyphyllin I induces autophagy and cell cycle arrest via inhibiting PdK1/Akt/mTOR signal and downregulating cyclin B1 in human gastric carcinoma HGc-27 cells

HnRNPR-ccNB1/cENPF axis contributes to gastric cancer proliferation and metastasis

Thioredoxin (TXN)

Selenium deficiency-induced thioredoxin suppression and thioredoxin knock down disbalanced insulin responsiveness in chicken cardiomyocytes through PI3K/Akt pathway inhibition

Porcine MAP3K5 analysis: Molecular cloning, characterization, tissue expression pattern, and copy number variations associated with residual feed intake

differential expression of apoptotic genes PdIA3 and MAP3K5 distinguishes between low-and high-risk prostate cancer

Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma

Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin

Not applicable.

The present study was supported by the National Natural 

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

XL, XWa, GL, YX and XS analyzed and interpreted the data. RY, FJ, cS and XWu performed the experiments. XL wrote the manuscript. All authors read and approved the final manuscript. XL and XS confirm the authenticity of all the raw data.

Not applicable.

Not applicable.

The authors declare that they have no competing interests.